Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2019

Open Access 01-10-2019 | Clostridioides Difficile | Original Article

Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner

Authors: Michał Piotrowski, Dorota Wultańska, Piotr Obuch-Woszczatyński, Hanna Pituch

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2019

Login to get access

Abstract

The aim of this study was to investigate the effects that prebiotic and candidates for prebiotics on Clostridium difficile strains to adhere to various human epithelial cell lines and to compare the adhesive properties of specific C. difficile strains. We also sought to examine the effect of different concentrations of fructooligosaccharides and mannose on the formation of biofilms by C. difficile strains. The influence of cellobiose, fructooligosaccharides, inulin, mannose, and raffinose on the adherence properties of various C. difficile strains, including motile 630, non-motile M120, and 10 clinical motile ribotype 027 strains, to non-mucous secreting HT-29, mucous secreting HT-29 MXT, and CCD 841 CoN cells lines. The most effective prebiotics were used in biofilm formation assays. We demonstrated that all C. difficile strains adhered to all cell lines. However, the C. difficile M120 non-motile strain was statistically more likely to adhere to all three cell lines (CFU median, 40) compared to the motile strains (CFU median, 3; p < 0.001). Furthermore, among the carbohydrates examined, only fructooligosaccharides and mannose were found to significantly decrease adhesion (p < 0.001) of C. difficile strains. Alternatively, using a biofilm assay, we observed, via confocal laser scanning microscopy, that sub-inhibitory concentrations (1%) of fructooligosaccharides and mannose functioned to increase biofilm formation by C. difficile. We demonstrated that specific prebiotics and candidate prebiotics exhibit varying anti-adhesive properties towards C. difficile in vitro and that treatment with sub-inhibitory concentrations of prebiotics can cause an increase in biofilm formation by C. difficile.
Literature
8.
go back to reference Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50:6334–6343PubMed Lesuffleur T, Barbat A, Dussaulx E, Zweibaum A (1990) Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50:6334–6343PubMed
11.
go back to reference Van Loo J, Coussement P, De Leenheer L et al (1995) On the presence of inulin, oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 35:525–552CrossRef Van Loo J, Coussement P, De Leenheer L et al (1995) On the presence of inulin, oligofructose as natural ingredients in the Western diet. Crit Rev Food Sci Nutr 35:525–552CrossRef
14.
go back to reference van Zanten GC, Krych L, Röytiö H et al (2014) Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. FEMS Microbiol Ecol 90:225–236. https://doi.org/10.1111/1574-6941.12397 CrossRefPubMed van Zanten GC, Krych L, Röytiö H et al (2014) Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. FEMS Microbiol Ecol 90:225–236. https://​doi.​org/​10.​1111/​1574-6941.​12397 CrossRefPubMed
18.
go back to reference Kumar A, Davenport KW, Vuyisich G et al (2018) Complete genome sequences of historic Clostridioides difficile food-dwelling Ribotype 078 strains in Canada identical to that of the historic human clinical strain M120 in the United Kingdom. Microbiol Resour Announc 7:pii: e00853–18. https://doi.org/10.1128/MRA.00853-18 CrossRef Kumar A, Davenport KW, Vuyisich G et al (2018) Complete genome sequences of historic Clostridioides difficile food-dwelling Ribotype 078 strains in Canada identical to that of the historic human clinical strain M120 in the United Kingdom. Microbiol Resour Announc 7:pii: e00853–18. https://​doi.​org/​10.​1128/​MRA.​00853-18 CrossRef
19.
go back to reference Stubbs D, Brazier JS, O’Neill JL, Duerden BI (1999) PCR targeted to the 16S–23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463PubMedPubMedCentral Stubbs D, Brazier JS, O’Neill JL, Duerden BI (1999) PCR targeted to the 16S–23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 37:461–463PubMedPubMedCentral
21.
go back to reference Pantosti A, Cerquetti M, Colangeli R, D’Ambrosio F (1994) Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay. J Med Microbiol 41:191–196CrossRef Pantosti A, Cerquetti M, Colangeli R, D’Ambrosio F (1994) Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay. J Med Microbiol 41:191–196CrossRef
26.
go back to reference Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotic galactooligosaccharides reduce adherence of entheropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928CrossRef Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotic galactooligosaccharides reduce adherence of entheropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928CrossRef
Metadata
Title
Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner
Authors
Michał Piotrowski
Dorota Wultańska
Piotr Obuch-Woszczatyński
Hanna Pituch
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2019
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-019-03635-7

Other articles of this Issue 10/2019

European Journal of Clinical Microbiology & Infectious Diseases 10/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.